← Leaderboards
Eduardo M Sotomayor
University Of South Florida
$9,082,073
Attributed
$9,994,494
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $966.6K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,994,494 · 6
By mechanism
R01$8,434,794 · 4
P50$1,378,584 · 1
K08$181,116 · 1
Top collaborators
- Jianguo Tao5 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Xiaohong Mary Zhang$1,801,948
- Hong-Gang Wang$14,593,079
- Marcia N Gordon$6,420,165
- David Morgan$15,699,395
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMolecularResponseIn VivoCellsImmuneNeoplastic CellBaseImmunityAntigen-Presenting CellsTumorT-LymphocyteAntigensGeneticTumor AntigensT Cell ResponseCd4 Positive T LymphocytesMalignant NeoplasmsMediatingInhibitor/AntagonistLaboratoriesHistonesPathway InteractionsImmune Tolerance
Grant awards (36)
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy$351,691
R01 · FY2019 · CA · contact PI
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy$362,569
R01 · FY2018 · CA · contact PI
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy$362,569
R01 · FY2017 · CA · contact PI
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet$287,702
P50 · FY2017 · CA · contact PI
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy$362,569
R01 · FY2016 · CA · contact PI
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet$271,916
P50 · FY2016 · CA · contact PI
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy$385,444
R01 · FY2015 · CA · contact PI
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet$266,054
P50 · FY2015 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$156,462
R01 · FY2015 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$125,394
R01 · FY2015 · CA · contact PI
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet$276,508
P50 · FY2014 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$273,400
R01 · FY2014 · CA · contact PI
Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas$425,222
R01 · FY2013 · CA · contact PI
Augmenting the Immunogenicity of Melanoma Through Manipulation of Histone Deacet$276,404
P50 · FY2013 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$264,944
R01 · FY2013 · CA · contact PI
Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas$453,876
R01 · FY2012 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$281,856
R01 · FY2012 · CA · contact PI
Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas$455,617
R01 · FY2011 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$281,856
R01 · FY2011 · CA · contact PI
Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas$488,216
R01 · FY2010 · CA · contact PI
Solid tumors induced T-cell tolerance$247,903
R01 · FY2009 · CA · contact PI
Solid tumors induced T-cell tolerance$247,903
R01 · FY2008 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$275,105
R01 · FY2007 · CA · contact PI
Solid tumors induced T-cell tolerance$243,422
R01 · FY2007 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$283,322
R01 · FY2006 · CA · contact PI
Solid tumors induced T-cell tolerance$250,692
R01 · FY2006 · CA · contact PI
Regulation of Cross-Tolerance to Tumor Antigens$290,140
R01 · FY2005 · CA
Solid tumors induced T-cell tolerance$256,725
R01 · FY2005 · CA
Regulation of Cross-Tolerance to Tumor Antigens$290,140
R01 · FY2004 · CA
Solid tumors induced T cell Tolerance$195,750
R01 · FY2004 · CA
Regulation of Cross-Tolerance to Tumor Antigens$287,915
R01 · FY2003 · CA
Solid tumors induced T cell Tolerance$195,750
R01 · FY2003 · CA
Solid tumors induced T cell Tolerance$179,503
R01 · FY2002 · CA
Solid tumors induced T cell Tolerance$158,839
R01 · FY2001 · CA
MECHANISM(S) INVOLVED IN TUMOR INDUCED TOLERANCE$90,558
K08 · FY2001 · CA
MECHANISM(S) INVOLVED IN TUMOR INDUCED TOLERANCE$90,558
K08 · FY2000 · CA